Beyond exhaustion: T cell fitness for next generation of immunotherapy for hematological cancer
T cell-directed immunotherapies have transformed the treatment of hematological malignancies, but durable benefit remains limited by relapse, poor persistence, incomplete immune reconstitution and infection. These outcomes depend not only on target-ant…